• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

Exelixis

Anonymous board for Exelixis
Replies
34
Views
5K
anonymous
Replies
9
Views
9K
anonymous
Replies
1
Views
577
anonymous
Replies
17
Views
6K
anonymous
Replies
3
Views
2K
anonymous
Replies
2
Views
2K
anonymous
Replies
0
Views
3K
anonymous
Replies
0
Views
2K
anonymous
Replies
0
Views
5K
anonymous